Kalvista Pharmaceuticals Inc (OQ:KALV)

Business Focus: Biopharmaceuticals

Competitors with Recent Insider Filings
Biogen (OQ:BIIB)
BioMarin Pharmaceutical (OQ:BMRN)
Allakos (OQ:ALLK)
Latest 10 SEC filings (by transaction date) for KALV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Mar 20/19 Mar 18/19 Venrock Healthcare Capital Partners II, L.P. Indirect Ownership Common Stock S - Open market or private sale -500,000 $28.75
Mar 20/19 Mar 18/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -7,246 $26.70
Mar 20/19 Mar 18/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -255,224 $26.70
Mar 15/19 Mar 14/19 Crockett Thomas Andrew Direct Ownership Common Stock S - Open market or private sale -3,000 $30.16
Mar 6/19 Mar 5/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -893 $23.04
Mar 6/19 Mar 5/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -31,439 $23.04
Mar 6/19 Mar 4/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -1,197 $22.91
Mar 6/19 Mar 4/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -42,181 $22.91
Feb 21/19 Feb 21/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -4,764 $20.60
Feb 21/19 Feb 21/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -167,779 $20.60
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for KALV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Mar 20/19 Mar 18/19 Venrock Healthcare Capital Partners II, L.P. Indirect Ownership Common Stock S - Open market or private sale -500,000 $28.75
Mar 20/19 Mar 18/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -7,246 $26.70
Mar 20/19 Mar 18/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -255,224 $26.70
Mar 15/19 Mar 14/19 Crockett Thomas Andrew Direct Ownership Common Stock S - Open market or private sale -3,000 $30.16
Mar 6/19 Mar 5/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -893 $23.04
Mar 6/19 Mar 5/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -31,439 $23.04
Mar 6/19 Mar 4/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -1,197 $22.91
Mar 6/19 Mar 4/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -42,181 $22.91
Feb 21/19 Feb 21/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -4,764 $20.60
Feb 21/19 Feb 21/19 Svlsf Iv, Llc Direct Ownership Common Stock S - Open market or private sale -167,779 $20.60
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $KALV

StockTwits